Claim Missing Document
Check
Articles

Found 24 Documents
Search

Liver Histopathological Analysis in The Acute Toxicity Test of Shallot (Allium cepa L.) Peel Extract in Rats (Rattus norvegicus) Aprilya Pratiwi, Nadilla; Dewi, Rosita; Agustina, Dini; Helianti, Dina; Rachmania, Sheilla
Journal of Agromedicine and Medical Sciences Vol. 11 No. 3 (2025)
Publisher : Faculty of Medicine, Universitas Jember

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.19184/ams.v11i3.53736

Abstract

Shallot (Allium cepa L.) contains bioactive compounds with antioxidant effects. In addition to the tuber, the shallot’s peel is a rich source of flavonoids with demonstrated capacity to mitigate oxidative stress. Prior studies have evaluated the antioxidant efficacy of shallot peel in ameliorating organ damage and have established its maximum effective dose. The subsequent step required for its potential therapeutic application is toxicity test. This study aimed to analyze the liver histopathological changes in the acute toxicity test of shallot peel extract (SPE) in rats based on OECD TG 420. This research was an experimental with a post-test-only control group design. Five female rats were used as the control group administered dimethyl sulfoxide (DMSO), while 5 female rats were used in the treatment group administered SPE at 5,000 mg/kg body weight (BW) (one of them had been used for a preliminary test with the same dosage). On day 15, a necropsy was conducted, followed by histopathological observation of the hematoxylin-eosin (HE)-stained liver histopathological slide. The damage to hepatocytes was evaluated using Manja Roenigk criteria. The average histopathological score per liver cell of the control group was 1.226 ± 0.0065 and the treatment group was 1.235±0.0079. The Mann-Whitney test showed that the liver histopathological score of the treatment group was not different from that of the control group (p>0.05). It can be concluded that SPE 5,000 mg/kg does not show acute toxic effects in rats, with LD₅₀ estimated at >5,000 mg/kg according to OECD standards.
Specific Sequence Motif of Var Gene as Predictor of Malaria Outcome Erma Sulistyaningsih; Rosita Dewi; Sheilla Rachmania; Irawan Fajar Kusuma; Sahrir Sillehu
Elkawnie Vol. 10 No. 1 (2024)
Publisher : Faculty of Science and Technology Universitas Islam Negeri Ar-Raniry

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22373/ekw.v10i1.14808

Abstract

Abstract: The Var gene family encodes for Plasmodium falciparum Erythrocyte Membrane Protein-1 (PfEMP1), a protein responsible for malaria pathogenesis. One of the variants, the var D gene, is hypothesized as a predictor of clinical malaria outcomes. The study aimed to investigate the association between the expression of the var D gene and clinical malaria outcomes. Blood spots on filter paper from uncomplicated and severe malaria patients were collected for DNA and RNA extraction. The RNA was reverse-transcribed into cDNA. DNA and cDNA were amplified by Polymerase Chain Reaction (PCR) technique using specific var D primer, and PCR products were electrophorized in 1% agarose. DNA amplification resulted in double bands of approximately 230 bp and 250 bp in uncomplicated and severe malaria samples. However, the cDNA amplification generated a single band of 230 bp from four out of five severe malaria samples. The existence of band solely in severe malaria transcript suggested its involvement in the pathogenesis of severe malaria. In conclusion, the expression of var D gene-specific sequence can be a potential predictor of severe malaria outcomes.Abstrak: Famili gen var mengkode Plasmodium falciparum Erythrocyte Membrane Protein-1 (PfEMP1), suatu protein yang berperan penting dalam proses patogenesis malaria. Salah satu variannya, gen var D, diduga merupakan prediktor gambaran klinis malaria. Penelitian ini bertujuan untuk mengetahui hubungan antara ekspresi gen var D  dan gambaran klinis malaria. Sampel berupa tetesan darah pada kertas filter dari pasien malaria tanpa komplikasi dan malaria berat dikumpulkan untuk diekstraksi DNA dan RNAnya. RNA selanjutnya di trankripsi reverse menjadi cDNA. DNA dan cDNA diamplifikasi dengan teknik PCR menggunakan primer spesifik var D dan produk PCR dielektroforesis menggunakan agarosa 1 %. Amplifikasi DNA menghasilkan beragam pita berukuran sekitar 230 bp dan 250 bp pada sampel malaria tanpa komplikasi dan malaria berat, tetapi amplifikasi cDNA hanya menunjukkan satu pita berukuran 230 bp pada 4 dari 5 sampel malaria berat. Keberadaan pita hanya pada sampel malaria berat mengindikasikan peran gen ini dalam patogenesis malaria berat. Disimpulkan bahwa gen var D dapat ditemukan pada sampel malaria tanpa komplikasi dan berat, namun ekpresi gen tersebut dapat menjadi prediktor yang potensial  timbulnya manifestasi klinis malaria berat.
Increased of Spleen White Pulp Diameter Post Dbl2β-Pfemp1 Recombinant Protein Injection in Wistar Rats: Pre-Clinical Study for Malaria Vaccine Development Erma Sulistyaningsih; Nindya Audatus Sa’diyah; Irawan Fajar Kusuma; Rosita Dewi; Sheilla Rachmania
Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan Vol 18 No 1 (2024): Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan
Publisher : Fakultas Kedokteran UPN Veteran Jakarta Kerja Sama KNPT

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33533/jpm.v18i1.7451

Abstract

Malaria is a major infectious disease worldwide, and vaccination is essential for disease control. The Plasmodium falciparum Erythrocyte Membrane Protein-1 (PfEMP1) is a potential malaria vaccine candidate due to its involvement in pathogenesis. Injection of DBL2β-PfEMP1 recombinant protein in animal models induces IgG and CD4+ production and inhibits binding with host endothelial receptors. This study aimed to analyze the spleen immune response by measuring the white pulp diameter. The experimental study used Wistar rats (Rattus norvegicus) that were divided into four groups, a control group and three treatment groups, which were injected with 100, 150, and 200 μg of DBL2β-PfEMP1 protein. Injection was done thrice with three-week intervals (days 0, 21, and 42). On day 56, rats were euthanized, and spleens were prepared for histology examination. The white pulp diameter increased along with increasing the dose of protein. The ANOVA test showed a significant difference between groups (p=0.001). The posthoc Bonferroni test showed a significant difference between the control and the 150 and 200 μg groups and the 100 μg and 200 μg groups. In conclusion, the DBL2β-PfEMP1 recombinant protein injection increased the spleen white pulp diameter in Wistar rats, and the 200 μg dose resulted in the highest increase.
CD4 Response to Duffy-Binding-Like Domain 2β of PfEMP1 Recombinant Protein for Malaria Vaccine Development Sulistyaningsih, Erma; Nafisa, Tsabita; Dewi, Rosita; Rachmania, Sheilla; Kusuma, Irawan Fajar
Elkawnie Vol. 12 No. 2 (2026): Article In Press
Publisher : Faculty of Science and Technology Universitas Islam Negeri Ar-Raniry

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22373/ekw.v12.i2.35878

Abstract

Abstract: A malaria vaccine based on Plasmodium falciparum antigen is essential in controlling malaria morbidity and mortality. The Duffy-binding-like domain 2β of Plasmodium falciparum erythrocyte membrane protein 1 (DBL2β-PfEMP1) is a malaria subunit vaccine candidate expected to prevent severe malaria. Meanwhile, subunit vaccines often elicit a weak immune response. This study aimed to analyze the CD4 response induced by several doses of DBL2β-PfEMP1 recombinant protein injection. This was a post-test-only true experimental study using 30 male Wistar rats (Rattus norvegicus) aged 2-3 months, weighing 150-250 g. The rats were randomly assigned into two control groups: NaCl 0.9% and adjuvant groups, and four treatment groups: DBL2β-PfEMP1 0.75 mg/kgBW, 0.75 mg/kgBW + adjuvant, 1.5 mg/kgBW + adjuvant, and 2.25 mg/kgBW + adjuvant groups. Injection was performed subcutaneously twice on days 0 and 42, and the blood serum was collected on days 14 and 56 for CD4 measurement using an enzyme-linked immunosorbent assay (ELISA) method. The results showed that CD4 concentration tends to decrease with an increasing dose of the DBL2β-PfEMP1 protein, particularly in post-injection II. Analysis of the differences between groups using the Kruskal-Wallis test showed no significant differences with p=0.59 in post-injection I and p=0.68 in post-injection II, and the Wilcoxon signed rank test to examine the differences across injections within each group showed no significant differences (p>0.05) in all groups. The results indicated no statistically significant differences in CD4 concentration post DBL2β-PfEMP1 recombinant protein injection in Wistar rats. Further studies examining other induced immune responses should be conducted to emphasize the DBL2β-PfEMP1 recombinant protein as a malaria vaccine candidate. Abstrak: Vaksin malaria berbasis antigen Plasmodium falciparum penting untuk mengendalikan morbiditas dan mortalitas akibat malaria. Duffy-binding-like domain 2β dari Plasmodium falciparum Erythrocyte Membrane Protein 1 (DBL2β-PfEMP1) merupakan salah satu kandidat vaksin malaria subunit yang diharapkan mampu mencegah malaria berat. Namun, umumnya vaksin subunit menginduksi respon imun yang lemah. Penelitian ini bertujuan untuk menganalisis respon CD4 setelah injeksi beberapa dosis protein rekombinan DBL2β-PfEMP1. Sebanyak 30 tikus Wistar jantan berusia 2-3 bulan dengan berat 150-250 g dibagi ke dalam dua kelompok kontrol: NaCl dan adjuvan, dan empat kelompok perlakuan: DBL2β-PfEMP1 0,75 mg/kgBB, 0,75 mg/kgBB + adjuvan, 1,5 mg/kgBB + adjuvan, and 2,25 mg/kgBB + adjuvan. Injeksi subkutan dilakukan dua kali pada hari ke-0 dan 42. Serum dikoleksi pada hari ke-14 dan 56 untuk pemeriksaan CD4 menggunakan metode ELISA. Hasil pengukuran menunjukkan bahwa konsentrasi CD4 cenderung menurun seiring dengan peningkatan dosis protein rekombinan, terutama setelah injeksi II. Analisis perbedaan tiap kelompok menggunakan Kruskal-Wallis test menunjukkan tidak ada perbedaan yang signifikan dengan p=0,59 setelah injeksi I dan p=0,68 setelah injeksi II. Dan analisis menggunakan Wilcoxon signed rank test untuk menilai perbedaan tiap kelompok antar injeksi menunjukkan semua kelompok tidak ada perbedaan bermakna (p>0,05).  Hasil ini mengindikasikan bahwa injeksi protein rekombinan DBL2β-PfEMP1 menginduksi respon CD4 yang tidak signifikan. Penelitian lanjutan dengan menilai respon imun lain diperlukan untuk menekankan potensi protein ini sebagai kandidat vaksin malaria.